The p53 Tumor-Suppressor Gene
- 14 May 1992
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (20) , 1350-1352
- https://doi.org/10.1056/nejm199205143262008
Abstract
OVER the past 15 years an examination of cancerous tissues has led to the identification of alterations in a number of genes that regulate cell growth and proliferation.1 These mutations have been identified in two distinct categories of genes, oncogenes and tumor-suppressor genes. Typically, mutations in oncogenes occur in one of the two alleles of the gene, and they act in a fashion dominant to the wild-type allele. Consequently, they are "gain of function" mutations that constitutively or permanently signal the cell to divide. Mutations in oncogenes appear to arise spontaneously in somatic tissues over the lifetime of the organism, . . .Keywords
This publication has 11 references indexed in Scilit:
- Germline Mutations of the p53 Tumor-Suppressor Gene in Children and Young Adults with Second Malignant NeoplasmsNew England Journal of Medicine, 1992
- Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with SarcomaNew England Journal of Medicine, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.Genes & Development, 1991
- Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndromeNature, 1990
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- Expression of recessive alleles by chromosomal mechanisms in retinoblastomaNature, 1983
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971